APP and Alzheimer disease: In certain mouse models, such as APPPS1 mice, this elevated activity involves abnormal purinergic Ca2+ signalling [117,118], although recent research has also indicated a decrease in sensory-evoked astrocyte responsiveness in AD mice with APP and PS1 mutations [119].